SAN ANTONIO -- Remimazolam (Byfavo) is poised to open a new frontier in anesthesiology, but caution is warranted to ensure off-label use does not devolve into the Wild West. Growing interest in the ...
PAION initiated a dedicated safety study of Remimazolam in American Society of Anesthesiologists classification III to IV patients undergoing colonoscopy as part of the U.S. Phase III program. 1. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results